Viewing Study NCT01868061


Ignite Creation Date: 2025-12-24 @ 12:01 PM
Ignite Modification Date: 2026-03-01 @ 12:17 AM
Study NCT ID: NCT01868061
Status: COMPLETED
Last Update Posted: 2017-05-19
First Post: 2013-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module